Literature DB >> 35722847

Predisposing factors involved in the aetiology of Molar Incisor Hypomineralization: a case-control study.

S Bagattoni1, E Carli2, M R Gatto3, I Gasperoni3, G Piana3, L Lardani2.   

Abstract

AIM: The aetiology of Molar Incisor Hypomineralisation (MIH) is currently unclear. Over time, several aetiological hypotheses have come forward, including pre- and perinatal medical problems and postnatal illness. The aim of this case-control study is the identification of possible predisposing factors involved in MIH aetiology.
METHODS: Methods Study Design: By hypothesising the probability of at least one predisposing factor present 2.5 times more in MIH cases than in controls, with an estimated prevalence of MIH patients requiring therapy equal to 30%, at a unilateral alpha level of 5% and a power of 80%, 63 couples of subjects are needed with an allocation ratio of 1:1; individual matching for age and gender was carried out. After clinical examination, 78 children with MIH (EAPD criteria) were recruited (mean age 9.36 years). An anamnestic form filled-in by a parent was used to collect data on possible predisposing factors including demographic characteristics, pregnancy, birth, childhood medical illness and medications' intake. STATISTICS: One-tail McNemar chi square test was used to evaluate the significance of the association between predisposing factor and MIH; odds ratio and 95% confidence intervals were computed.
CONCLUSION: A multifactorial aetiology may be advocated for MIH development; in particular, further investigations are required to confirm and clarify the role of genetic factors.

Entities:  

Mesh:

Year:  2022        PMID: 35722847     DOI: 10.23804/ejpd.2022.23.02.13

Source DB:  PubMed          Journal:  Eur J Paediatr Dent        ISSN: 1591-996X            Impact factor:   2.231


  1 in total

1.  Prevalence of and factors associated with molar-incisor hypomineralisation in schoolchildren in the canton of Basel-Landschaft, Switzerland.

Authors:  Andreina Grieshaber; Tuomas Waltimo; Asin A Haschemi; Judith Erb; Richard Steffen; Michael M Bornstein; Eva M Kulik
Journal:  Clin Oral Investig       Date:  2022-07-26       Impact factor: 3.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.